Association Between Pseudoexfoliation Syndrome and Diabetes Mellitus
The Possible Association Between Pseudoexfoliation Syndrome and Diabetes Mellitus in an Egyptian Population
1 other identifier
observational
100
0 countries
N/A
Brief Summary
Pseudoexfoliation syndrome (PEX) is characterized by the deposition of a distinctive fibrillar material in the anterior segment of the eye and was first described in 1917 by Lindberg. It is frequently associated with open angle glaucoma, known as pseudoexfoliation glaucoma, which is one of the most common identifiable forms of secondary open angle glaucoma worldwide. Despite extensive research, the exactchemical nature of the fibrillar material is unknown. It is believed to be secreted multifocally in the iris pigment epithelium, the ciliary epithelium, and the peripheral anterior lens epithelium.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2019
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 11, 2018
CompletedFirst Posted
Study publicly available on registry
November 14, 2018
CompletedStudy Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 14, 2021
CompletedNovember 14, 2018
November 1, 2018
1.9 years
November 11, 2018
November 11, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
the percentage of diabetic patients with pseudo-exfoliation syndrome
slit lamp examination of all diabetic patients to get the percentage of those with pseudo-exfoliation syndrome
10 minutes
Study Arms (2)
study group
includes patients who will be diagnosed with Pseudoexfoliation syndrome
control group
age matched controls who do not have Pseudoexfoliation syndrome
Interventions
1. Presence of white grayish exfoliation material on the anterior lens capsule and / or the pupillary margin. 2. Poor pupillary dilatation due to atrophy of the dilator pupillae muscle. 3. The presence of pseudoexfoliative material (PXF)in cilliary processes and zonules. 4. presence of PXF material scattered on corneal endothelium. 5. Flecks of the exfoliative material on the anterior chamber which leads to glaucoma.
Eligibility Criteria
patients who will be diagnosed with pseudo-exfolian syndrome
You may qualify if:
- Phakic patients presenting to Ophthalmology outpatient clinic Of Assiut University Hospital.
You may not qualify if:
- Patients with previous intraocular surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
November 11, 2018
First Posted
November 14, 2018
Study Start
January 1, 2019
Primary Completion
December 1, 2020
Study Completion
March 14, 2021
Last Updated
November 14, 2018
Record last verified: 2018-11